T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients-Reference-Cited by-同舟云学术

T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients

Published:2016-09-10 Issue:14 Volume:30 Page:2149-2158
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Mummert Christiane,Hofmann Christian,Hückelhoven Angela G.,Bergmann Silke,Mueller-Schmucker Sandra M.,Harrer Ellen G.,Dörrie Jan,Schaft Niels,Harrer Thomas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference42 articles.

1. Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study;Llibre;Antiviral Ther,2012

2. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation;Shan;Immunity,2012

3. Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape;Sewell;Stem Cells,2000

4. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation;Goulder;J Exp Med,1997

5. Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins;Yang;J Virol,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells;PLOS Pathogens;2023-12-15

2. Molecular mechanisms by which the HIV-1 latent reservoir is established and therapeutic strategies for its elimination;Archives of Virology;2023-08

3. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses;Frontiers in Immunology;2021-04-28

4. CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy;Frontiers in Immunology;2019-08-09

5. Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy;Cancer Immunology, Immunotherapy;2019-06-18